SCHEMBL24614713

SCHEMBL24614713

c1ccc(-c2cc(-c3ccccc3)cc(-c3c4ccccc4c(-c4cc5cc(-c6cc(-c7c8ccccc8c(-c8ccccc8)c8ccccc78)cc(-c7c8ccccc8c(-c8ccccc8)c8ccccc78)c6)c6oc7ccccc7c6c5c5c4oc4ccccc45)c4ccccc34)c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
CDC14B O60729 2/20 0.36
CDC14A Q9UNH5 2/20 0.36
ADORA2A P29274 1/20 0.36
KDM4E B2RXH2 3/20 0.35
GAA P10253 2/20 0.35
HSD17B10 Q99714 2/20 0.35
MEN1 O00255 2/20 0.35
CYP3A4 P08684 2/20 0.35
MAPT P10636 2/20 0.35
HPGD P15428 2/20 0.35
KMT2A Q03164 2/20 0.35
ALPI P09923 1/20 0.35
PKM P14618 1/20 0.35
CASP3 P42574 1/20 0.35
RECQL P46063 1/20 0.35
BLM P54132 1/20 0.35
CASP7 P55210 1/20 0.35
CASP6 P55212 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24614814 0.97 CA1 (0.39) CA1CA2CDC14BCDC14AADORA2A
SCHEMBL24614733 0.96 CA1 (0.38) CA1CA2CDC14BCDC14AADORA2A
SCHEMBL24614779 0.96 CDC14B (0.38) CA1CA2CDC14BCDC14AADORA2A
SCHEMBL24614724 0.95 CDC14B (0.38) CA1CA2CDC14BCDC14AADORA2A
SCHEMBL24614738 0.92 CDC14B (0.41) CA1CA2CDC14BCDC14AADORA2A
SCHEMBL24614797 0.92 CA1 (0.41) CA1CA2CDC14BCDC14AADORA2A
SCHEMBL24614668 0.92 CA1 (0.43) CA1CA2CDC14BCDC14AADORA2A
SCHEMBL24614652 0.91 PLA2G2A (0.39) CA1CA2CDC14BCDC14AADORA2A
SCHEMBL24614915 0.91 CDC14B (0.40) CA1CA2CDC14BCDC14AADORA2A
SCHEMBL24614916 0.89 PLA2G2A (0.40) CA1CA2CDC14BCDC14AADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220223801-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2022-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220223801-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES TMEM109, PIEZO1, L1CAM CA1 1283/4885CA2 3674/4885CDC14B 4839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.